Gregg's congenital rubella patients 60 years later

Medical Journal of Australia

Volumn 177, Issue 11-12, 2002, Pages 664-667

  Forrest, Jill M ^a,b   Turnbull, Fiona M ^a   Sholler, Gary F ^a,c   Hawker, Richard E ^a,c   Martin, Frank J ^a,d   Doran, Trevor T ^e   Burgess, Margaret A ^a,d  

^a CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^b NCIRS   (Australia)

^c Adolph Basser Cardiac Institute   (Australia)

^d UNIVERSITY OF SYDNEY   (Australia)

^e AUSTRALIAN RED CROSS BLOOD SERVICE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

HLA A1 ANTIGEN; HLA ANTIGEN; HLA B8 ANTIGEN; HLA DR3 ANTIGEN; RUBELLA ANTIBODY;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ADULTHOOD; AORTA VALVE DISEASE; ARTICLE; AUSTRALIA; AUTOIMMUNE DISEASE; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; COHORT ANALYSIS; CONGENITAL RUBELLA SYNDROME; DEATH; DIABETES MELLITUS; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; HEARING IMPAIRMENT; HLA MATCHING; HUMAN; INTRAUTERINE INFECTION; LIVER CIRRHOSIS; MALE; MALIGNANT NEOPLASTIC DISEASE; MEDICAL ASSESSMENT; OUTCOMES RESEARCH; PREVALENCE; SURVIVAL; TERATOGENESIS;

EID: 0037011527     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2002.tb05003.x     Document Type: Article

References (29)

1. Gregg NMcA. Congenital cataract following German measles in the mother. Trans Ophthalmol Soc Aust 1941; 3: 35-46.
2. Weller TH, Neva FA. Propagation in tissue culture of cytopathic agents from patients with rubella-like illness. Proc Soc Exp Biol Med 1962; 111: 215-225.
3. Parkman PD, Buescher EL, Artenstein MS. Recovery of rubella virus from army recruits. Proc Soc Exp Biol Med 1962; 111: 225-230.
4. Swan C, Tostevin AL, Moore B, et al. Congenital defects in infants following infectious diseases during pregnancy. Med J Aust 1943; 2: 201-210.
5. Gregg NMcA. Further observations on congenital defects in infants following maternal rubella. Trans Ophthalmol Soc Aust 1944; 4: 119-131.
6. Menser MA, Reye RDK. The pathology of congenital rubella: A review written by request. Pathology 1974: 6: 215-622.
7. Gregg NMcA, Ramsay Brevis W, Heseltine M, et al. The occurrence of congenital defects in children following maternal rubella during pregnancy. Med J Aust 1945; 2: 122-126.
8. Lancaster HO. Deafness as an epidemic disease in Australia. A note on census and institutional data. BMJ 1951; 2: 1429-1432.
9. Menser MA, Forrest JM, Slinn RF, et al. Rubella viuria in a 29-year-old woman with congenital rubella. Lancet 1971; 2: 797-798.
10. Fuccillo DA, Steele RW, Hensen SA, et al. Impaired cellular immunity to rubella virus in congenital rubella. Infect Immun 1974; 9: 81-84.
11. Menser MA, Dods L, Harley JD. A twenty-five year follow-up of congenital rubella. Lancet 1967; 2: 1347-1350.
12. Forrest JM, Menser MA, Burgess JA. High frequency of diabetes mellitus in young adults with congenital rubella. Lancet 1971; 2: 332-334.
13. McIntosh ADG, Menser MA. A fifty-year follow-up of congenital rubella. Lancet 1992; 340: 414-415.
14. Otto CM, Lind BK, Kitzman DW, et al. Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly. N Engl J Med 1999; 341: 142-147.
15. Akasaka T, Yoshikawa J, Yoshida K, et al. Age-related valvular regurgitation: A study by pulsed Doppler echocardiography. Circulation 1987; 76: 262-265.
16. Dunstan DW, Zimmet PZ, Welborn TA, et al. The rising prevalence of diabetes and impaired glucose tolerance. The Australian Diabetes, Obesity and Lifestyle Study. Diabetes Care 2002; 25: 829-834.
17. Kenrick KG, Slinn RF, Dorman DC, Menser MA. Immunoglobulins and rubella-virus antibodies in adults with congenital rubella. Lancet 1968; 1: 548-551.
18. Honeyman MC, Dorman DC, Menser MA, et al. HL-A antigens in congenital rubella and the role of antigens 1 and 8 in the epidemiology of natural rubella. Tissue Antigens 1975; 5: 12-18.
19. Ou D, Mitchell LA, Metzger DL, et al. Cross-reactive rubella virus and glutamic acid decarboxylase (65 and 67) protein determinants recognised by T cells of patients with type 1 diabetes mellitus. Diabetologia 2000; 43: 750-762.
20. Congenital rubella - 50 years on. Lancet 1991; 337: 668.
21. O'Donnell N. History of congenital rubella syndrome. J Vocational Rehabil 1996; 6: 149-157.
22. Munro S. A survey of late emerging manifestations of congenital rubella in Canada. Presented at the NUD Conference on Late Manifestations of Rubella in Congenitally Deafblind Persons, Dronninglund, Denmark, May 8-12, 1999.
23. Reef S, Plotkin S, Cordero JF, et al. Preparing for elimination of congenital rubella syndrome (CRS). Summary of a workshop on CRS elimination in the United States. Clin Infect Dis 2000; 31: 85-95.
24. Townsend JJ, Baringer JR, Wolinsky JS, et al. Progressive rubella panencephalitis. Late onset after congenital rubella. N Engl J Med 1975; 292: 990-993.
25. Weil ML, Itabashi H, Cremer NE, et al. Chronic progressive panencephalitis due to rubella virus simulating subacute sclerosing panencephalitis. N Engl J Med 1975; 292: 994-998.
26. Sullivan EV, Burgess MA, Forrest JF. The epidemiology of rubella and congenital rubella in Australia, 1991 to 1997. Commun Dis Intell 1999; 23: 209-214.
27. Cutts FT, Robertson SE, Diaz-Ortega J-L, Samuel R. Part 1: The Burden of Disease from CRS. Control of Rubella and Congenital Rubella Syndrome (CRS) in Developing Countries. Geneva: Department of Vaccines and Biologicals, World Health Organization; 2000: 2-15.
28. Gilbert GL. Infections in pregnant women. Med J Aust 2002; 176: 229-236.
29. Burgess MA. Gregg's rubella legacy 1941-1991. Med J Aust 1992; 156: 138-139.